[1]
P. Mahapol, “THE PREVALENCE AND ASSOCIATED RISK FACTORS OF REBOUND HYPERTHYROIDISM IN GRAVES’ DISEASE AFTER ANTI-THYROID DRUG DOSE REDUCTION (PARAGON STUDY)”, J ASEAN Fed Endocr Soc, vol. 38, no. S3, p. 104, Nov. 2023.